Spotted fever
MONDO:0001195A type of tick-borne disease which presents on the skin caused by bacteria of the genus Rickettsia.
Also known as: spotted fever, spotted fever rickettsiae disease, spotted fever rickettsiosis, fever, spotted, fevers, spotted, spotted fever Group Rickettsioses, spotted fever Group rickettsiosis, spotted fevers
10 clinical trials for this condition and its sub-types, 0 tagged with Spotted fever itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Spotted fever
-
Rocky mountain spotted fever 1 trial
-
African tick-bite fever 0 trials
-
Flinders island spotted fever 0 trials
-
Japanese spotted fever 0 trials
-
Queensland tick typhus 0 trials
-
5 sub-types
- Astrakhan spotted fever 0 trials
- Far eastern spotted fever 0 trials
- Indian tick typhus 0 trials
- Israeli tick typhus 0 trials
- Boutonneuse fever 0 trials
-
Rickettsia helvetica spotted fever 0 trials
-
Rickettsia parkeri spotted fever 0 trials
-
Siberian tick typhus 0 trials
-
Pseudotyphus of California 0 trials
-
Rickettsialpox 0 trials
-
New antibiotic shows promise for newborns with dangerous infections
Disease control CompletedThis study looked at how the antibiotic cefiderocol works in hospitalized infants under 3 months old with suspected or confirmed gram-negative bacterial infections. Researchers measured drug levels in the blood and checked for side effects in 30 babies. The goal was to find the r…
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New antibiotic shows promise for kids with tough infections
Disease control CompletedThis study tested the safety and how the body processes the antibiotic cefiderocol in hospitalized children aged 3 months to 18 years with serious bacterial infections. The goal was to see if the drug is safe and how it works in the body. 53 children participated, and the study i…
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New antibiotic shows promise for kids with tough infections
Disease control CompletedThis study tested a new antibiotic called MK-7655A in 115 children from birth to 18 years old who had serious bacterial infections. The goal was to see if the drug is safe and works better than standard treatments. Children were randomly assigned to receive either the new drug or…
Phase 2/3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC